RE: Today’s Rns9 Jun 2021 10:21
What on earth is happening regarding PAH Trust NHS’s extended free use of Bleepa? They’ve had it to play with free for 18 months and must know by now whether they’d pay for it in future. Amazing there was no mention in the update given it’s been a flagship trial, extended for COVID 19 purposes.
Also there is the question regarding the approaching renewal date in July of Papworth’s contract, which included Bleepa (presumably at nil additional cost):
London, 21 May 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces Royal Papworth Hospital NHS Foundation Trust ("Trust") has renewed its contract for clinical PACS (picture archiving and communication system) services with Feedback Medical Ltd, a wholly owned subsidiary of the Company. The renewal will incorporate an upgrade to service, providing the Trust access to Bleepa®, Feedback's flagship imaging-based communication platform.
The contract, set for a term of 14 months, relates to Feedback's Cadran PACS which has provided core medical imaging services to the Trust since 2001. The contract includes the use of Bleepa® as an upgrade to Cadran Web Viewer and will see Bleepa® made available to all clinicians at the Trust.
The lack of an update regarding Pennine is a concern. This is a business, not a charity. Come on Tom, give shareholders proper information, not waffle.